CorMedix Inc. (United States) is listed on the Nasdaq and has a market capitalization of $378.92 million, with shareholders equity totaling $461.71 million.
The company employs approximately 35 people and operates in the Health sector, within the Pharmaceutical Products industry.
Over the past 12 months, CorMedix Inc. reported $412.49 million in revenue, generating net income of $63.89 million.
Key financial metrics include a P/E ratio of 5.93, a price-to-book (P/B) ratio of 0.82, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker CRMD.